Oxygenta Pharmaceutical Ltd

AGM Details

• Date and time: 21-08-2026, 10:30 AM to 11:15 AM, via VC/OAVM.
• Record date for entitlements: 14-08-2026.

Resolutions

• Resolution 1: Adopt audited standalone financial statements for FY2025-26; passed.
• Resolution 2: Re-appoint Balasubba Reddy Mamilla as director on rotation; passed.
• Resolution 3: Appoint Amireddy Venkatesu Reddy as Whole-time Director; passed.
• Resolution 4: Appoint Janardhana Reddy Yeddula as Independent Director; passed.
• Resolution 5: Approve sale/purchase related party transactions with Virupaksha Organics Limited; passed.
• Resolution 6: Approve loan and guarantee related party transactions with Virupaksha Organics Limited; passed.
• Resolution 7: Ratify cost auditor remuneration for FY2026-27; passed.

Overall outcome

• All seven resolutions were passed; ordinary and special business approved.

AGM Details

• Date and time: 21 August 2026, 10:30 AM IST.
• Mode: Video Conference / AVM.
• Quorum: 75 members attended via VC.
• Record date: 14 August 2026.

Key Resolutions

• Resolution 1 (Ordinary): Adopt audited standalone financial statements for FY2025-26 with reports.
• Resolution 2 (Ordinary): Re-appoint Balasubba Reddy Mamilla as Director.
• Resolution 3 (Special): Appoint Amireddy Venkatesu Reddy as Whole-time Director.
• Resolution 4 (Special): Appoint Janardhana Reddy Yeddula as Independent Director.
• Resolution 5 (Ordinary): Approve material related party sale/purchase with Virupaksha Organics Limited.
• Resolution 6 (Ordinary): Approve material related party loan and guarantee with Virupaksha Organics Limited.
• Resolution 7 (Ordinary): Ratify remuneration to Cost Auditor for FY2026-27.

Voting Results

• All resolutions passed with high in-favor percentages.

Material Related Party Transactions

• Sale and Purchase with Virupaksha Organics Limited approved.
• Loan and Guarantee with Virupaksha Organics Limited approved.

Director Changes

• Amireddy Venkatesu Reddy appointed Whole-time Director.
• Janardhana Reddy Yeddula appointed Independent Director.
• Balasubba Reddy Mamilla re-appointed as Director (rotating).

Auditors

• No changes to statutory auditors announced.

Other Material Approvals

• No other material approvals disclosed.

No AGM details provided in the excerpt for Oxygenta Pharmaceutical Ltd

Financial snapshot

• Revenue from operations: 11,298.19 Lakh in 2025-26, up from 10,929.86.
• Net loss after tax: 1,757.17 Lakh in 2025-26, vs 1,029.83.
• Total comprehensive income: 52.54 Lakh in 2025-26; prior year (−10.73).
• EPS: -4.75 per share for 2025-26.
• Equity negative at (4,268.68) Lakh; gearing -2.52x.
• Total borrowings: 10,956.68 Lakh; cash & cash equivalents: 41.90 Lakh.
• No breaches in debt covenants.
• India revenue: 11,296.73 Lakh; export: 1.46.
• Dividend: no dividend declared for 2025-26.

Business & geography

• Single operating segment: Pharmaceuticals.
• Geography: India revenue 11,296.73; Export 1.46.
• Non-current assets in India: 4,634.41.
• Major customer Virupaksha Organics Limited contributed 7,216.06 (63.87%) of revenue.

Capital structure & liquidity

• Equity capital: 3,698.35; total equity: (4,268.68).
• Borrowings: Non-current 7,528.60; current 3,428.08; total 10,956.68.
• Net debt: 10,741.77; cash & bank balances: 173.00; cash equivalents: 41.90.
• Gearing ratio: −2.52x; no covenant breaches.

Related party transactions

• Holding company Virupaksha Organics Limited holds 56.50% equity.
• FY2025-26 VOL RPTs: Sales 6,665.37; Purchases 6,275.55; Inter‑company borrowings 3,550.00; Interest 169.34; Total 16,660.27.
• FY2026-27 proposed RPTs with VOL: Inter‑corporate borrowing 10,000; Guarantees 10,000; Total 20,000.
• RPTs approved by Audit Committee; ordinary course and arm's length; related-party voting restrictions apply.

Governance & leadership changes

• Amireddy Venkatesu Reddy appointed Whole-Time Director for 3 years from 23-05-2026; remuneration Rs 6-8 LPM.
• Janardhana Reddy Yeddula appointed Independent Director for 5 years from 23-05-2026.
• CFO Prasad Reddy Battinapatla appointed 07-11-2025.
• CS Kumkum Bajaj appointed 14-08-2025; Dolly Mandhan resigned 14-08-2025.
• Promoter group reclassification: VOL became promoter; post open offer.
• Board size six: three independent, three executive, one non-exec.

Audit & risk management

• Statutory auditors AM Reddy & D.R. Reddy; unmodified opinion.
• Secretarial Auditor Aakanksha Dubey & Co; no qualifications.
• Internal Audit: Suryachandra & Associates; reappointed for 2026-27.
• Going concern: material uncertainty due to negative net worth; VOL support and revival plan; Rs 2000 Lakh bank facility; expected EBITDA positive in FY27.

Risks & outlook

• Customer concentration risk: VOL accounted for 63.87% of revenue.
• Deferred tax asset: 1740.74 Lakh; realization depends on future profitability.
• ECL on trade receivables: 130.09 Lakh; VOL as major debtor.
• API industry risks: raw material costs, regulation, currency and supply-chain disruptors.
• Outlook: revival plan underway; promoter support expected to restore profitability.

CSR & sustainability

• CSR not applicable; company voluntarily contributed Rs 4.30 Lakh.
• Green initiatives: e-communication with shareholders.
• Climate-related disclosures and risk monitoring noted in Annexure V.

AGM Details

• Date and time: 21 August 2026 at 10:30 A.M.
• Mode: Video Conferencing / Other Audio Visual Means
• Record/Book closure: 15.08.2026 to 21.08.2026
• Remote e-voting: 18-20 Aug 2026; cut-off: 14 Aug 2026

Resolutions Put to Vote

• Ordinary: Adopt Audited Financial Statements for year ended 31 March 2026
• Ordinary: Re-appoint Balasubba Reddy Mamilla as Director by rotation
• Special: Appoint Amireddy Venkatesu Reddy as Director and Whole Time Director for 3 years with remuneration Rs 6-8 lakh/month
• Special: Appoint Janardhana Reddy Yeddula as Independent Director for five years
• Ordinary: Approve material RPT with VOL for sale/purchase up to Rs 250 Cr
• Ordinary: Approve material RPT (loan and guarantees) with VOL up to Rs 200 Cr
• Ordinary: Ratify Cost Auditor remuneration for FY 2026-27

Voting Results

• Final results not disclosed here; to be announced at AGM and posted on BSE and e-voting portal

Dividend

• Dividend: No dividend proposed or declared for the year 2025-26

Director Changes

• Board changes since 2025 include resignations and new appointments amid open offer
• Resignations: six directors on 20.06.2025; two more on 18.08.2025
• Appointments: multiple directors added on 20.06.2025; Amireddy Venkatesu Reddy and Janardhana Reddy Yeddula appointed 23.05.2026

Auditors

• Statutory auditors: A.M. Reddy & D.R. Reddy; tenure to 2027-28; remuneration approx Rs 8.5 L
• Secretarial auditors: Aakanksha Dubey & Co; 5-year term (2025-2030)
• Internal auditors: Suryachandra & Associates; appointed for 2026-27
• Cost auditors: PCR & Associates; remuneration Rs 75,000; for 2026-27

Material Related Party Transactions

• Holding Company VOL is promoter; RPTs include sale/purchase up to Rs 250 Cr and loans/guarantees up to Rs 200 Cr

Other material approvals

• Open offer details and related party disclosures are covered in the accompanying statements

Cost Auditor Appointment

• Appointed M/s. PCR & Associates, Cost Accountants, as Cost Auditors for FY 2026-27.
• Date of appointment: 27 July 2026; term for FY 2026-27; subject to shareholders' ratification.
• Profile: PCR & Associates is a leading cost accounting firm offering cost audit and related services.
• Disclosure: Not Applicable; no director relationships disclosed.

POSH Committee Reconstitution

• Re-constituted the POSH Committee of the Board with effect from 27 July 2026.
• Presiding Officer: Ms. Kurapati Divya; Internal Members: Jyothi Kuchipudi, B. Rajitha, S. Chandraleka, Yempally Sindhu.
• External Member: Ms. D. Rajeswari.

Board meeting reschedule details

• Postponed from 25 July 2026 to 27 July 2026.
• Agenda includes unaudited quarterly results for quarter ended 30 June 2026 and related limited review.
• Other business with chair's permission.

Dematerialisation processing status

• RTA confirmed dematerialisation during the quarter was processed and details furnished to all stock exchanges.
• Physical certificates for dematerialisation were mutilated and cancelled after verification; depositories updated as registered owner within 15 days.

Meeting Details

• Board meeting scheduled for Saturday, 23 May 2026.
• Meeting will be held at the company's corporate office.

Key Agenda Items

• Audited financial results for the quarter and year ended 31 March 2026.
• Audit report for the year ended 31 March 2026.

Other Notes

• No additional material items disclosed.